SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CNSI Cambridge Neuroscience -- Ignore unavailable to you. Want to Upgrade?


To: nigel bates who wrote (635)3/2/2001 5:11:05 PM
From: Cheryl Galt  Read Replies (1) | Respond to of 675
 
Jan 26/01 --- CeNeS (LSE: CEN - news) said Phase II clinical trials of its morphine alternative drug M6G showed positive results in post-operative pain management.

Parallel clinical trials are taking place to determine the medication's use to relieve pain in hip-replacement surgery. Shares in the biotech company improved 2.5p (4.5%) to 58.5p